Latest Breaking News On - Clinical research division - Page 4 : comparemela.com

AstraZeneca (AZN) announces Voydeya approved in the US

AstraZeneca (AZN) announces Voydeya approved in the US
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marc dunoyerBart scottEuropean unionUniversity of washington medical centerEuropean medicines agencyDivision of hematologyDrug administrationLancet haematologyWashington medical centerClinical research divisionFred hutchinson cancer centerChief executive officerFunctional assessmentChronic illness therapyBreakthrough therapyEuropean medicines

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH

VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesGlasgow cityVoydeyaplus solirisorBart scottMarc dunoyerEuropean hematology associationEuropean unionUniversity of washington medical centerEuropean medicines agencyAlexion pharmaceuticals incDrug administrationDivision of hematologyLancet haematologyWashington medical centerClinical research division

Dr Banerjee on Nivolumab Use After CAR T-Cell Therapy Progression in Myeloma and NHL

Rahul Banerjee, MD, FACP, discusses the use of nivolumab in multiple myeloma or non-Hodgkin lymphoma after progression following CAR T-cell therapy.

Rahul banerjeeFred hutchinson cancer centerUniversity of washingtonDivision of hematologyClinical research divisionCellular therapyCellular therapy meetingsMultiple myelomaNon hodgkin lymphoma

Dr Lee on 3-Year Follow-Up Data From the ROCKstar Trial of Belumosudil in cGVHD

Stephanie Lee, MD, MPH, discusses 3-year follow-up data from the phase 3 ROCKstar Study of belumosudil in cGVHD.

Stephanie leePatricia giuliani oliver pressFred hutchinson cancer centerCancer researchClinical research divisionOliver press endowed chairCellular therapy meetingsTransplantation and cellular therapy meetingsOnclive tv

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01

Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

University hospitalUnited statesNordrhein westfalenBaylor college of medicineBaylor universityFrance generalSan franciscoGregorio maraMothaffarf rimawiMiguel martinJoycea oshaughnessySaraa hurvitzInstitut curieForschungs gmbGruppo italiano mammellaJaye thompson